Core Scientific stock soars 30%: here's why

Core Scientific (CORZ) shares surged nearly 30% following a Wall Street Journal report indicating CoreWeave (CRWV) is in advanced talks to acquire the bitcoin mining and hosting company. This strategic acquisition aims to secure CoreWeave critical high-density, energy-efficient data center capacity, including Core Scientific's 1.3 gigawatts of contracted power, essential for scaling AI compute infrastructure and vertically integrating operations. While a deal could be announced within weeks and offers significant strategic advantages for CoreWeave, investors are cautioned that the current rally may have priced in a premium, the acquisition is not yet confirmed, and limited analyst coverage suggests potential downside if the deal falls through.

Analysis

Core Scientific (CORZ) shares experienced a significant rally of nearly 30% following a Wall Street Journal report of a potential acquisition by CoreWeave (CRWV). The strategic rationale for CoreWeave is clear: securing essential infrastructure to meet the explosive demand for AI compute. Core Scientific's portfolio, which includes over 1.3 gigawatts of contracted power, offers the high-density capacity CoreWeave needs to vertically integrate its operations, reduce long-term hosting costs, and gain tighter control over its AI infrastructure deployment. This move builds upon an existing commercial relationship, where a 12-year contract for 590 megawatts of hosting is already projected to generate over $10 billion in revenue for CORZ. However, significant risks temper the outlook. The acquisition remains unconfirmed, and the recent stock appreciation, marking a 150% gain from its year-to-date low, may have already priced in a substantial takeover premium. A major red flag for investors is the valuation disconnect, with the sole Wall Street analyst covering the stock setting a price target of $5.0, implying a potential downside of nearly 70% from its current trading level.

Key Decisions for Investors

• Investors should recognize that Core Scientific's current valuation is highly speculative and contingent on an unconfirmed M&A event, posing significant downside risk if the deal is denied or fails to materialize.
• Given the stock has rallied roughly 30% on the news, it is prudent to consider that a potential acquisition premium may already be priced in, limiting further upside.
• Monitor for official confirmation or denial of the deal, as a denial could trigger a sharp price correction back towards pre-report levels, in line with the substantial downside suggested by the current analyst price target.
• For investors tracking the AI sector, this potential deal highlights the intense competition for power and data center capacity, underscoring the strategic value of infrastructure assets like those held by Core Scientific.